Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection-Reference-Cited by-同舟云学术

Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection

Published:2011-03 Issue:11 Volume:29 Page:2100-2109
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

van Dissel Jaap T.,Soonawala Darius,Joosten Simone A.,Prins Corine,Arend Sandra M.,Bang Peter,Tingskov Pernille Nyholm,Lingnau Karen,Nouta Jan,Hoff Søren T.,Rosenkrands Ida,Kromann Ingrid,Ottenhoff Tom H.M.,Doherty T. Mark,Andersen Peter

Funder

European Commission

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference30 articles.

1. Planning to improve global health: the next decade of tuberculosis control;Maher;Bull World Health Organ,2007

2. The success and failure of BCG – implications for a novel tuberculosis vaccine;Andersen;Nat Rev Microbiol,2005

3. Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations;Hanekom;PLoS Med,2008

4. Beresford B, Sadoff JC. Update on research and development pipeline: tuberculosis vaccines. Clin Infect Dis 2010;50(Suppl. 3 (May 15)):S178–83.

5. New vaccines for tuberculosis;Kaufmann;Lancet,2010

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A mucosal vaccine formulation against tuberculosis by exploiting the adjuvant activity of S100A4—A damage-associated molecular pattern molecule;Vaccine;2024-11

2. The role of ESAT-6 in tuberculosis immunopathology;Frontiers in Immunology;2024-04-03

3. Tuberculosis vaccine developments and efficient delivery systems: A comprehensive appraisal;Heliyon;2024-02

4. A Mucosal Vaccine Formulation Against Tuberculosis by Exploiting the Adjuvant Activity of S100a4—A Damage-Associated Molecular Pattern Molecule;2024

5. A novel multistage antigens ERA005f confer protection against Mycobacterium tuberculosis by driving Th-1 and Th-17 type T cell immune responses;Frontiers in Immunology;2023-11-07